Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /home/fintekas/public_html/wp-content/plugins/social-networks-auto-poster-facebook-twitter-g/inc/nxs_functions_engine.php on line 173

Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /home/fintekas/public_html/wp-content/plugins/social-networks-auto-poster-facebook-twitter-g/inc/nxs_functions_engine.php on line 180

Warning: Cannot modify header information - headers already sent by (output started at /home/fintekas/public_html/wp-content/plugins/social-networks-auto-poster-facebook-twitter-g/inc/nxs_functions_engine.php:173) in /home/fintekas/public_html/wp-content/plugins/wp-super-cache/wp-cache-phase2.php on line 1197
Chinese Pre-Profit Cancer Drug Developer Tot Biopharm Files For HK IPO – FintekAsia


Chinese Pre-Profit Cancer Drug Developer Tot Biopharm Files For HK IPO


Warning: Use of undefined constant php - assumed 'php' (this will throw an Error in a future version of PHP) in /home/fintekas/public_html/wp-content/themes/colornews-child/template-parts/content-single.php on line 53

News Source: China Money Network.

Tot Biopharm, a private equity-backed Chinese biopharmaceutical company, has filed for an initial public offering (IPO) in Hong Kong on Monday under the rules that allow pre-profit companies to float shares on the stock exchange.

Chinese Pre-Profit Cancer Drug Developer Tot Biopharm Files For HK IPO comes origi...



Warning: Use of undefined constant php - assumed 'php' (this will throw an Error in a future version of PHP) in /home/fintekas/public_html/wp-content/themes/colornews-child/template-parts/content-single.php on line 108

This news article comes via China Money Network, who is the copyright owner of this information and news. FintekAsia.com has licensed the rights to this article and any republication or re-distribution in whole or in part of this content is strictly prohibited without the express consent of

You May Also Like